Columvi is used in treating hematologic malignancies ... We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or ...

Roche’s CD20xCD3 bispecific antibody Columvi has improved survival when used as a second-line therapy for diffuse large B-cell lymphoma (DLBCL) in a phase 3 trial, setting up regulatory filings ...